New Jersey Law Journal | Analysis
By njlawjournal | September 18, 2017
In the Law Journal's Intellectual Property & Life Sciences supplement, articles focus on the new challenges presented by 3D printing, and the…
By Jean E. Dassie and Christine A. Gaddis | September 18, 2017
On May 22, the Supreme Court of the United States decided 'TC Heartland v. Kraft Foods Group Brands,' which fundamentally changed the patent venue landscape.
By Gerard P. Norton and Michael S. Montgomery | September 18, 2017
On June 12, the U.S. Supreme Court issued a unanimous opinion in 'Sandoz v. Amgen,' a highly anticipated case concerning key provisions of the Biologics Price Competition and Innovation Act, part of the larger Patient Protection and Affordable Care Act of 2009.
By Max Mitchell | September 13, 2017
The judge overseeing pelvic mesh mass tort litigation said the New Jersey-based defendant may have had a "strong" relationship with a Pennsylvania mesh-manufacturer, but he questioned whether that relationship would be enough to allow the Keystone State to retain jurisdiction over 90 pelvic mesh cases involving out-of-state plaintiffs.
By Tom McParland | September 13, 2017
The former head of Valeant Pharmaceuticals International Inc.' s dermatology division was unable to convince a court to end a class action lawsuit accusing the generic drugmaker and its executives of engaging in a massive scheme to fraudulently inflate the company's stock prices.
By Sue Reisinger | August 24, 2017
Michael Ullmann, general counsel of Johnson & Johnson will have a lot to think about in the aftermath of the massive verdict.
By njlawjournal | New Jersey Law Journal | August 23, 2017
Claims of Favorable Reverse Payment Settlement Agreements Were Sufficient to Constitute Allegation of Anticompetitive Activity
By Charles Toutant | August 21, 2017
The U.S. Court of Appeals for the Third Circuit has overturned the dismissal of two antitrust suits over "reverse settlements" in which patent holders sought to delay the sale of generic versions of blockbuster drugs.
By Amanda Bronstad | August 18, 2017
In lobbying and litigation, the U.S. Chamber of Commerce and Johnson & Johnson often draw from the same playbook. One major connection is John Beisner, head of mass torts at Skadden Arps.
By Max Mitchell | August 17, 2017
Mylan has agreed to pay $465 million to settle claims that the Pennsylvania-based drugmaker misclassified its EpiPen allergy medication to avoid paying Medicaid rebates.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
McManimon, Scotland & Baumann, LLC is seeking talented and motivated Associate Attorneys with 3-7 years of experience working closely wi...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS